% | $
Quotes you view appear here for quick access.

GW Pharmaceuticals plc Message Board

flshtogo 29 posts  |  Last Activity: Oct 14, 2013 2:52 PM Member since: Oct 12, 2006
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • flshtogo flshtogo Oct 14, 2013 2:52 PM Flag

    Agree. I posted PUGE as informational purpose only. GWP should be aware PUGE may be in path to infringe on GW patented transmucosal delivery systems.

    Sentiment: Strong Buy

  • GWP decade ahead of competitors THC and cannaboid delivery method. $62 target is conservative.

    There is no US approved drug to treat PTSD. Cannoboid may be the cure.
    OTC: PUGE Cannabis BioTech is investigating alternatives such as topical applications and infusing active ingredients into foods and beverages, which will open up the benefits to a significantly larger segment of the population. The company is also exploring sophisticated transmucosal delivery systems (administered through the mucous membranes).

    According to a recent Pew Research report, for the first time in more than 40 years a majority of Americans favor legalization of marijuana use. The manner in which it is consumed is producing a fast-growing industry in alternative delivery methods. The Wall Street Journal reported the $1.7 billion U.S. #$%$ market will quadruple in size during the next five years.

    PROFIT: Projected cannabis sales are $3 billion in 2014 and $6 billion in 2016. In US 20 states plus the District of Columbia have legalized cannabis for medical reasons and the list of states will continue to grow.

    Sentiment: Strong Buy

  • If GW is targeting diabetes it derivative study should be obesity prevention drugs. No other obesity pills have been FDA approved in US market use since Phen-phen which was disaster - heart attacks. Two companies who is in obesity cure is VVUS and ARNA, on speculation investors bid companys market share to over $1B in the last few months. One can only imagine if GW is successful in obesity drug (mentioned in company website study since 2007) the market cap easily in several billions. GW holds patents programmable inhibitors Nabiximols is a patented cannabinoid oromucosal mouth spray"USPTO: Not only does GW have claims directed to the method of sublingual delivery of the Sativex formulation, but it also has claims directed to the device within which it is contained," Gover added. "In total, we now have seven different patent families containing one or more pending or issued patents relating to Sativex." The issued patent is expected to expire in March 2021.

    Target price tripled might be convervative since two additional programs were not factored in.

    GW has a deep pipeline of additional cannabinoid product candidates, including two distinct compounds, GWP42004 and GWP42003, in Phase 2 clinical development for Type 2 diabetes and ulcerative colitis, respectively, and two additional programs expected to advance into Phase 1 and Phase 2 clinical trials in the next 12 months.

    Sentiment: Strong Buy

  • flshtogo by flshtogo Oct 10, 2013 11:23 AM Flag

    I am holding shares in the low teens and will not sell until north of $70s. I believe the stock will trade in the 30's when shutdown is over and debt ceiling have been passed. Saltivex fast track in FDA and scheduling will occur within few months not years IMHO. Twenties will be history very soon, load up the truck.

    Sentiment: Strong Buy

  • GWPH should close green today. Target of $60s the stock will see 40's this week. Everyone who is on sideline waiting for good entry point. Watch the surge in buying towards the close. GLTA

    Sentiment: Strong Buy

  • I also see the stock in $40s - low float. Wait until before end of trading trade - it sprints to close.

    Sentiment: Strong Buy

  • fjb...keep your small position. GWP.L london exh jump to $42.25 in one day so...can GWPH. GWPH trading in teens is history. Wait until FDA approves Saltivex in US market. $80's easy next year.

    Sentiment: Strong Buy

  • flshtogo flshtogo Oct 7, 2013 12:04 PM Flag

    Good call GWPH will be trading in $30s Monday. I am in low 10's can't believe GWPH trade as bullet train. Long term GWPH holding until FDA approves Saltivex and DEA scheduling date is released. GWPH got sexy legs "low float" it can trade in the $80's next year. GWP.L is in tear for the last month. I knew something was cooking the stock goes up 7 - 8 points without news for the last 2 weeks.

    Sentiment: Strong Buy

  • UA (underground stock alerts- google them ) to a BUY - GWPH with a new price $28. GWP.L trading at $104.50 up 17 points in two days.

    Sentiment: Strong Buy

  • Reply to

    Do you prefer Facebook or Twitter.

    by ruudkrul Oct 4, 2013 8:00 AM
    flshtogo flshtogo Oct 4, 2013 12:32 PM Flag

    Facebook use can get President re-elected. Hands down Facebook is the real King Kong of social media..

    Sentiment: Strong Buy

  • flshtogo flshtogo Oct 4, 2013 11:33 AM Flag

    Saltivex is the cannoboid King Kong. It is on FDA fast track for approval in US market early next year. Check out London Exh GWP.L the stock rocketted to over $100 up 13 points two days ago. GWPH will rocket to $50 when FDA approves Saltivex drug to be sold in US market.

    Sentiment: Strong Buy

  • It will be over $17 after hours

    Sentiment: Strong Buy

  • GWPH is going to explode next week to $20 by Friday 9/13. Today MM taking all the shares going down. GWPH target $20 in London GWP.L trading at $89 up 3+ with a target of $128. Be patient Longs and you will be rewarded. BIG NEWS coming.

    Sentiment: Strong Buy

  • Crystal ball predicts $12-$14 per share before deportation $9.

  • Reply to

    Lawsuit $5M retainer

    by smartvoi2 May 15, 2010 1:04 AM
    flshtogo flshtogo May 15, 2010 1:30 AM Flag

    Here comes the high flying lawyers steal STEC naked.

  • flshtogo flshtogo Apr 20, 2010 12:08 AM Flag

    There is hole in the ship so delicate if not plugged-in will see the ship - sink. Insider trading lawsuits will prevail - mark my words.

  • STEC or Moshayedi's own pockets?

    Most defendants would have been happy just to be off the hook in an expensive and time-consuming legal case SEC and 7 civil lawsuits. Never one to back down from a good fight, STEC should turn the tables on the SEC and file a lawsuit against them. The SEC clearly set out to embarrass STEC Moshayedi brothers to perhaps send them to prison, and they should not let the matter drop. Don't hold your breath STEC have proven record of incompetence in pursuit of their own wealth. They have seen the movie untouchables so many times.

  • The only person you MUST listen to is Spanspur. Read this message everday and you know....he is an honest Guy. Genius. Sorry longs.

    Think Back To The First Days Of The Fraud 24-Feb-10 01:00 pm The common had bounced up to the $18 level. STEC management had a cc and spoke in generalized glowing commentary about the future and the potential markets. The shear power of their proprietary product and the acceptance by customers. The problem was they were announcing deals and orders to existing clients........

    When I would mention that the company itself had the study that clearly stated in no uncertain terms that the world wide demand by the end of 2011 for enterprise SSD memory components was no greater than $400 million per year worldwide.

    STEC management holds a cc. A little over 2 weeks later Manouch announces via Yahoo that an order, supposedly unseen prior to the cc from a company which is in contact with their customers on a weekly basis, had come into view. Manouch announced that an additional $6 million in profit might be had. What occurred?


    Spanspur was dismissed as a lunatic, while everyone was acting like they had just discovered sex. When I brought up the study I was called even worse. So here we are today and the gross revenue for STEC for 2010 is now predicted to be $132 million per JP Morgan.

    Wow! You've been focked by Manouch and the Wall Street machine by design!

  • Reply to

    Shorts Scrambling To Cover

    by spanspur Feb 15, 2007 10:41 AM
    flshtogo flshtogo Feb 15, 2007 2:33 PM Flag

    STEC will not pre-announcement Q1 guidance because sales maybe low. The last CC was not impressive since CEO tapped dance when asked about Q1 outlook. I am without confidence the company will continue uptrend so I sold 80% of my position in the last few weeks bought at $4-$6 range and holding 5k shares just in case there is room for buyout.

    Mike M. founder was "eliminated" due to sale of commercial division but resigning from board seat a very bad sign and not make sense. One must speculate is the statement on Form 8K accurate or opposite? "Mr. Moshayedi's resignation as a director is not due to any disagreement with the Company on any matter relating to the Company's operations, policies and practices."

  • STEC stocks is safe for retirement funds. My post last Nov 2...loading up more STEC stocks below $8 is dirt cheap. I have close to 20,000 shares @ $3.75 - $7.90 range.

    I am very confident STEC will announce better than expected Q3 numbers.

    No guts no glory...

81.63+0.09(+0.11%)Aug 26 4:00 PMEDT